東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Enhanced endothelialization on surfa...

Xu, Hao.

Linked to FindBook

Google Book

Amazon

博客來

Enhanced endothelialization on surface modified poly(L-lactic acid).

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Enhanced endothelialization on surface modified poly(L-lactic acid)./
Author:	Xu, Hao.
Description:	117 p.
Notes:	Source: Dissertation Abstracts International, Volume: 71-07, Section: B, page: 4388.
Contained By:	Dissertation Abstracts International71-07B.
Subject:	Engineering, Biomedical. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3408969
ISBN:	9781124057361

Enhanced endothelialization on surface modified poly(L-lactic acid).
Xu, Hao.

Enhanced endothelialization on surface modified poly(L-lactic acid). - 117 p.

Source: Dissertation Abstracts International, Volume: 71-07, Section: B, page: 4388.

Thesis (Ph.D.)--The University of Texas at Arlington, 2010.

Current synthetic vascular grafts and polymer-coated drug-eluting stents (DES) have certain limitations, such as thrombosis and restenosis due to the incomplete recovery of vascular endothelial cells on their luminal sides. Surface modification of these materials is a viable method to enhance endothelialization. In this study, we proposed several strategies to modify poly(L-lactic acid) (PLLA), a promising material for vascular prostheses to enhance endothelialization on its surface. In the first approach, we modified the material surface with deposition of poly(vinylacetic acid) (PVAA) using plasma polymerization. PVAA films having different surface densities of --COOH groups or film thickness were created and characterized. Their effects on endothelial cell adhesion, proliferation, and function were studied. PVAA films with 9% -COOH surface density and 100 nm film thickness were found to be optimal for enhancing endothelialization. The mechanism for this enhancement might involve increased adsorption of fibronectin on its surface. In the second method, fibronectin was conjugated covalently with PVAA, which was deposited on PLLA, utilizing the rich --COOH of PVAA. Vascular Endothelial Growth Factor (VEGF) was subsequently conjugated with fibronectin for surface delivery of VEGF. Enhanced endothelial cells adhesion and proliferation was found on this modified PLLA surface, especially when VEGF receptor-genetically modified cells were used. Lastly, we coated PLLA with poly(1,8-octanediol-co-citrate) (POC)/poly(lactic-co-glycolic acid) (PLGA) microparticle composite. VEGF, fibroblast growth factor (FGF), and VEGF receptor plasmids were encapsulated in the PLGA microparticles for controlled release. Fibronectin and anti-CD34 antibody were, in turn, conjugated on top of POC to capture endothelial progenitor cells (EPC). It was found that the surface-modified PLLA successfully captured EPCs in a flowing condition, and rendered quick endothelialization on the surface. Using these strategies, enhanced endothelialization can be achieved on polymers such as PLLA, which naturally do not support endothelial cell growth, in order to reduce thrombosis and restenosis on vascular prostheses.

ISBN: 9781124057361Subjects--Topical Terms:

1017684
Engineering, Biomedical.

Enhanced endothelialization on surface modified poly(L-lactic acid).
LDR:03327nam 2200325 4500 001 1400808
005 20111015105930.5
008 130515s2010 ||||||||||||||||| ||eng d
020 $a 9781124057361
035 $a (UMI)AAI3408969
035 $a AAI3408969
040 $a UMI $c UMI
100 1 $a Xu, Hao. $3 1679901
245 1 0 $a Enhanced endothelialization on surface modified poly(L-lactic acid).
300 $a 117 p.
500 $a Source: Dissertation Abstracts International, Volume: 71-07, Section: B, page: 4388.
500 $a Adviser: Liping Tang.
502 $a Thesis (Ph.D.)--The University of Texas at Arlington, 2010.
520 $a Current synthetic vascular grafts and polymer-coated drug-eluting stents (DES) have certain limitations, such as thrombosis and restenosis due to the incomplete recovery of vascular endothelial cells on their luminal sides. Surface modification of these materials is a viable method to enhance endothelialization. In this study, we proposed several strategies to modify poly(L-lactic acid) (PLLA), a promising material for vascular prostheses to enhance endothelialization on its surface. In the first approach, we modified the material surface with deposition of poly(vinylacetic acid) (PVAA) using plasma polymerization. PVAA films having different surface densities of --COOH groups or film thickness were created and characterized. Their effects on endothelial cell adhesion, proliferation, and function were studied. PVAA films with 9% -COOH surface density and 100 nm film thickness were found to be optimal for enhancing endothelialization. The mechanism for this enhancement might involve increased adsorption of fibronectin on its surface. In the second method, fibronectin was conjugated covalently with PVAA, which was deposited on PLLA, utilizing the rich --COOH of PVAA. Vascular Endothelial Growth Factor (VEGF) was subsequently conjugated with fibronectin for surface delivery of VEGF. Enhanced endothelial cells adhesion and proliferation was found on this modified PLLA surface, especially when VEGF receptor-genetically modified cells were used. Lastly, we coated PLLA with poly(1,8-octanediol-co-citrate) (POC)/poly(lactic-co-glycolic acid) (PLGA) microparticle composite. VEGF, fibroblast growth factor (FGF), and VEGF receptor plasmids were encapsulated in the PLGA microparticles for controlled release. Fibronectin and anti-CD34 antibody were, in turn, conjugated on top of POC to capture endothelial progenitor cells (EPC). It was found that the surface-modified PLLA successfully captured EPCs in a flowing condition, and rendered quick endothelialization on the surface. Using these strategies, enhanced endothelialization can be achieved on polymers such as PLLA, which naturally do not support endothelial cell growth, in order to reduce thrombosis and restenosis on vascular prostheses.
590 $a School code: 2502.
650 4 $a Engineering, Biomedical. $3 1017684
690 $a 0541
710 2 $a The University of Texas at Arlington. $b Biomedical Engineering. $3 1264771
773 0 $t Dissertation Abstracts International $g 71-07B.
790 1 0 $a Tang, Liping, $e advisor
790 1 0 $a Nguyen, Kytai T. $e committee member
790 1 0 $a Tang, Liping $e committee member
790 1 0 $a Yang, Jian $e committee member
790 1 0 $a Chuong, Cheng-Jen $e committee member
790 1 0 $a Banerjee, Subhash $e committee member
790 $a 2502
791 $a Ph.D.
792 $a 2010
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3408969